Poly(-caprolactone)-carbon nanotube composite scaffolds for enhanced cardiac differentiation of human mesenchymal stem cells

Nanomedicine

Volumn 8, Issue 11, 2013, Pages 1763-1776

  Crowder, Spencer W ^a,b   Liang, Yi ^a   Rath, Rutwik ^a,b   Park, Andrew M ^a   Maltais, Simon ^c   Pintauro, Peter N ^a   Hofmeister, William ^d   Lim, Chee C ^c   Wang, Xintong ^a,b   Sung, Hak Joon ^a,b,c  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF TENNESSEE SPACE INSTITUTE   (United States)

Author keywords

carbon nanotube; cardiac differentiation; electrical conductivity; mesenchymal stem cell; poly caprolactone)

Indexed keywords

AZACITIDINE; BENZENE DERIVATIVE; CARBON NANOFIBER; CARBON NANOTUBE; MYOSIN HEAVY CHAIN ALPHA; N,N DIMETHYLFORMAMIDE; POLYCAPROLACTONE; RYANODINE RECEPTOR 2; TETRAHYDROFURAN; TRANSCRIPTION FACTOR NKX2.5; POLYESTER; TISSUE SCAFFOLD;

ACTIN FILAMENT; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; ELECTRIC CONDUCTIVITY; ELECTROSPINNING; ELECTROSTIMULATION; ENTHALPY; GENE EXPRESSION; GENETIC MARKER; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MELTING POINT; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; STEM CELL CULTURE; TRANSMISSION ELECTRON MICROSCOPY; YOUNG MODULUS; CELL CULTURE; CHEMISTRY; CYTOLOGY; MESENCHYMAL STROMA CELL; METHODOLOGY; PHYSIOLOGY; TISSUE ENGINEERING;

CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; MESENCHYMAL STROMAL CELLS; NANOTUBES, CARBON; POLYESTERS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84887259935     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.204     Document Type: Article

References (35)

1. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specifcation. Cell 126(4), 677-689 (2006). (Pubitemid 44233625)
2. Wang X, Boire TC, Bronikowski CM, Zachman AL, Crowder SW, Sung HJ. Decoupling polymer properties to elucidate mechanisms governing cell behavior. Tissue Eng. Part B Rev. 18(5), 396-404 (2012).
3. Martinelli V, Cellot G, Toma FM et al. Carbon nanotubes promote growth and spontaneous electrical activity in cultured cardiac myocytes. Nano Lett. 12(4), 1831-1838 (2012).
4. Serena E, Figallo E, Tandon N et al. Electrical stimulation of human embryonic stem cells: cardiac differentiation and the generation of reactive oxygen species. Exp. Cell Res. 315(20), 3611-3619 (2009).
5. Dvir T, Timko BP, Brigham MD et al. Nanowired three-dimensional cardiac patches. Nat. Nanotechnol. 6 (11), 720-725 (2011).
6. Kim DH, Provenzano PP, Smith CL, Levchenko A. Matrix nanotopography as a regulator of cell function. J. Cell Biol. 197(3), 351-360 (2012).
7. Chen SS, Fitzgerald W, Zimmerberg J, Kleinman HK, Margolis L. Cell-cell and cell-extracellular matrix interactions regulate embryonic stem cell differentiation. Stem Cells 25(3), 553-561 (2007). (Pubitemid 46354213)
8. Reilly GC, Engler AJ. Intrinsic extracellular matrix properties regulate stem cell differentiation. J. Biomech. 43(1), 55-62 (2009).
9. Povsic TJ, O'Connor CM. Cell therapy for heart failure: the need for a new therapeutic strategy. Expert Rev. Cardiovasc. Ther. 8(8), 1107-1126 (2010).
10. Wang F, Guan J. Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy. Adv. Drug Deliv. Rev. 62(7-8), 784-797 (2010).
11. Horwitz EM, Gordon PL, Koo WK et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl Acad. Sci. USA 99(13), 8932-8937 (2002). (Pubitemid 34693661)
12. Nagaya N, Fujii T, Iwase T et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am. J. Physiol. Heart Circ. Physiol. 287(6), H2670-H2676 (2004). (Pubitemid 39557139)
13. Li H, Yu B, Zhang Y, Pan Z, Xu W. Jagged 1 protein enhances the differentiation of mesenchymal stem cells into cardiomyocytes. Biochem. Biophys. Res. Commun. 341(2), 320-325 (2006). (Pubitemid 43152109)
14. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18(12), 1417-1426 (1995).
15. Xu W, Zhang X, Qian H et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp. Biol. Med. (Maywood) 229(7), 623-631 (2004). (Pubitemid 38878907)
16. Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J. Cell. Physiol. 211(1), 27-35 (2007). (Pubitemid 46363893)
17. Perin EC, Willerson JT, Pepine CJ et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA 307(16), 1717-1726 (2012).
18. Mooney E, Dockery P, Greiser U, Murphy M, Barron V. Carbon nanotubes and mesenchymal stem cells: biocompatibility, proliferation and differentiation. Nano Lett. 8(8), 2137-2143 (2008).
19. Meng X, Stout DA, Sun L, Beingessner RL, Fenniri H, Webster TJ. Novel injectable biomimetic hydrogels with carbon nanofbers and self assembled rosette nanotubes for myocardial applications. J. Biomed. Mater. Res. A 101(4), 1095-1102 (2012).
20. Mooney E, Mackle JN, Blond DJ et al. The electrical stimulation of carbon nanotubes to provide a cardiomimetic cue to MSCs. Biomaterials 33(26), 6132-6139 (2012).
21. Lee HH, Shin US, Jin GZ, Kim HW. Highly homogeneous carbon nanotube-polycaprolactone composites with various and controllable concentrations of ionically-modifed-MWCNTs. Bull. Korean Chem. Soc. 32(1), 157-161 (2011).
22. Gupta MK, Walthall JM, Venkataraman R et al. Combinatorial polymer electrospun matrices promote physiologically-relevant cardiomyogenic stem cell differentiation. PLoS ONE 6(12), e28935 (2011).
23. Crowder SW, Gupta MK, Hofmeister LH, Zachman AL, Sung HJ. Modular polymer design to regulate phenotype and oxidative response of human coronary artery cells for potential stent coating applications. Acta Biomater. 8(2), 559-569 (2012).
24. Christopherson GT, Song H, Mao HQ. The infuence of fber diameter of electrospun substrates on neural stem cell differentiation and proliferation. Biomaterials 30(4), 556-564 (2009).
25. Bianco A, Del Gaudio C, Baiguera S et al. Microstructure and cytocompatibility of electrospun nanocomposites based on poly(epsilon- caprolactone) and carbon nanostructures. Int. J. Artif. Organs 33(5), 271-282 (2010).
26. Clark MD, Krishnamoorti R. Dispersion of functionalized multiwalled carbon nanotubes. J. Phys. Chem. C 113(49), 20861-20868 (2009).
27. Saeed K, Park SY, Lee HJ, Baek JB, Huh WS. Preparation of electrospun nanofbers of carbon nanotube/polycaprolactone nanocomposite. Polymer 47(23), 8019-8025 (2006). (Pubitemid 44740024)
28. Purcell EM. Electricity and Magnetism. McGraw-Hill, Newton, MA, USA, 2 (1985).
29. Turnbull D. Kinetics of heterogeneous nucleation. J. Chem. Phys. 18(2), 198-203 (1950).
30. Qian Q, Qian H, Zhang X et al. 5-azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated kinase. Stem Cells Dev. 21(1), 67-75 (2011).
31. Ng WA, Grupp IL, Subramaniam A, Robbins J. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ. Res. 68(6), 1742-1750 (1991).
32. Bayes-Genis A, Roura S, Soler-Botija C et al. Identifcation of cardiomyogenic lineage markers in untreated human bone marrow-derived mesenchymal stem cells. Transplant Proc. 37(9), 4077-4079 (2005). (Pubitemid 43015257)
33. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105(1), 93-98 (2002). (Pubitemid 34049148)
34. Sorrentino V, Volpe P. Ryanodine receptors: how many, where and why? Trends. Pharmacol. Sci. 14(3), 98-103 (1993). (Pubitemid 23096442)
35. Kang PM, Haunstetter A, Aoki H, Usheva A, Izumo S. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ. Res. 87(2), 118-125 (2000). (Pubitemid 30616907)